Compare AANJANEYA LIFECARE with Pfizer - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs PFIZER - Comparison Results

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS PFIZER DR. DATSONS LABS/
PFIZER
 
P/E (TTM) x -10.9 35.9 - View Chart
P/BV x 0.2 6.1 2.7% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 DR. DATSONS LABS   PFIZER
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
PFIZER
Mar-19
DR. DATSONS LABS/
PFIZER
5-Yr Chart
Click to enlarge
High Rs1263,840 3.3%   
Low Rs312,080 1.5%   
Sales per share (Unadj.) Rs133.0455.0 29.2%  
Earnings per share (Unadj.) Rs0.293.8 0.2%  
Cash flow per share (Unadj.) Rs6.6109.4 6.0%  
Dividends per share (Unadj.) Rs022.50 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs128.8658.2 19.6%  
Shares outstanding (eoy) m31.6645.75 69.2%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.66.5 9.0%   
Avg P/E ratio x516.131.6 1,635.2%  
P/CF ratio (eoy) x11.827.1 43.8%  
Price / Book Value ratio x0.64.5 13.5%  
Dividend payout %024.0 0.0%   
Avg Mkt Cap Rs m2,477135,420 1.8%   
No. of employees `000NA2.6 0.0%   
Total wages/salary Rs m563,238 1.7%   
Avg. sales/employee Rs ThNM7,911.4-  
Avg. wages/employee Rs ThNM1,230.9-  
Avg. net profit/employee Rs ThNM1,630.7-  
INCOME DATA
Net Sales Rs m4,21120,815 20.2%  
Other income Rs m791,674 4.7%   
Total revenues Rs m4,28922,489 19.1%   
Gross profit Rs m5695,712 10.0%  
Depreciation Rs m204714 28.6%   
Interest Rs m43073 590.1%   
Profit before tax Rs m136,599 0.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m62,309 0.3%   
Profit after tax Rs m54,291 0.1%  
Gross profit margin %13.527.4 49.2%  
Effective tax rate %48.035.0 137.3%   
Net profit margin %0.120.6 0.6%  
BALANCE SHEET DATA
Current assets Rs m6,85227,167 25.2%   
Current liabilities Rs m6,7118,917 75.3%   
Net working cap to sales %3.387.7 3.8%  
Current ratio x1.03.0 33.5%  
Inventory Days Days16168 237.2%  
Debtors Days Days31830 1,058.0%  
Net fixed assets Rs m3,6738,862 41.4%   
Share capital Rs m317458 69.2%   
"Free" reserves Rs m3,76129,656 12.7%   
Net worth Rs m4,07830,113 13.5%   
Long term debt Rs m1,67125 6,683.2%   
Total assets Rs m12,63339,400 32.1%  
Interest coverage x1.091.5 1.1%   
Debt to equity ratio x0.40 49,357.2%  
Sales to assets ratio x0.30.5 63.1%   
Return on assets %3.411.1 31.1%  
Return on equity %0.114.2 0.8%  
Return on capital %7.722.1 34.7%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Exports (fob) Rs m964NA-   
Imports (cif) Rs m602NA-   
Fx inflow Rs m964428 225.1%   
Fx outflow Rs m607786 77.2%   
Net fx Rs m357-358 -99.7%   
CASH FLOW
From Operations Rs m1,345978 137.5%  
From Investments Rs m-2,256351 -642.3%  
From Financial Activity Rs m-1,200-1,099 109.2%  
Net Cashflow Rs m-2,111231 -914.5%  

Share Holding

Indian Promoters % 4.5 0.0 -  
Foreign collaborators % 0.0 63.9 -  
Indian inst/Mut Fund % 0.0 7.5 -  
FIIs % 1.4 4.9 27.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 23.7 397.0%  
Shareholders   20,807 85,207 24.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   CIPLA  SANOFI INDIA  ALKEM LABORATORIES  ORCHID PHARMA LTD  NOVARTIS  

Compare DR. DATSONS LABS With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 70 Points Higher; Telecom and Banking Stocks Advance(Closing)

Indian share markets traded on a positive note throughout the day and ended marginally higher. The BSE Sensex rose over 350 points intraday.

Related Views on News

PFIZER Announces Quarterly Results (2QFY20); Net Profit Up 61.0% (Quarterly Result Update)

Oct 29, 2019 | Updated on Oct 29, 2019

For the quarter ended September 2019, PFIZER has posted a net profit of Rs 2 bn (up 61.0% YoY). Sales on the other hand came in at Rs 6 bn (up 9.1% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (1QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PFIZER has posted a net profit of Rs 1 bn (up 22.8% YoY). Sales on the other hand came in at Rs 5 bn (up 6.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

PFIZER Announces Quarterly Results (4QFY19); Net Profit Up 4.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, PFIZER has posted a net profit of Rs 1 bn (up 4.7% YoY). Sales on the other hand came in at Rs 5 bn (up 3.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (3QFY19); Net Profit Up 51.2% (Quarterly Result Update)

Jan 25, 2019 | Updated on Jan 25, 2019

For the quarter ended December 2018, PFIZER has posted a net profit of Rs 1 bn (up 51.2% YoY). Sales on the other hand came in at Rs 5 bn (up 12.5% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

These 10 Days Are Crucial for Getting Rich in the Smallcap Rebound(Profit Hunter)

Nov 5, 2019

How to avoid the most common investing mistake and make the most of the smallcap rebound.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS - JUBILANT LIFE SCIENCES COMPARISON

COMPARE DR. DATSONS LABS WITH

MARKET STATS